“眼血1号”治疗外伤性玻璃体积血临床观察  

Effect of "Eye Blood No.1" on Traumatic Vitreous Hemorrhage

作　　者：寇列玲 沈兰珂 王满华[1] 宋建斌[1] 

机构地区：[1]安康市中医医院眼科,陕西安康725000

出　　处：《湖南中医药大学学报》2017年第10期1121-1123,共3页Journal of Hunan University of Chinese Medicine

基　　金：陕西省中医药管理局十大病种创新计划项目"中西医结合治疗早期玻璃体积血"

摘　　要：目的观察"眼血1号"治疗眼球外伤(钝挫伤)致玻璃体积血临床效果。方法按来院就诊顺序随机分为对照组、治疗组,两组均口服维生素C+安络血,治疗组加服自拟院内处方"眼血1号",6 d为1个疗程,治疗1~3个疗程观察服用眼血1号前、后1周和1月的视力情况和临床疗效。结果治疗组视力明显提高,治疗组总有效率78.95明显高于对照组总有效率55%,两组间比较差异有统计学意义(P<0.05)。结论院内自拟处方"眼血1号"治疗外伤性玻璃体积血可止血不留瘀,提高患者视力和生活质量、降低致盲率,值得基层医院推广应用。Objective To observe the effect of ＂Eye Blood No.1＂ on traumatic vitreous hemorrhage. Methods The patients were randomly divided into the control group and the treatment group, the two groups were orally administrated with vitamin C ＋ Anluo blood, the treatment group was additionally added self-made prescription ＂Eye Blood No.1＂ for 1-3 courses.The best corrected visual acuity, intraocular pressure, anterior chamber reaction, glass volume of blood absorption before medication, after one week and one month for using ＂Eye Blood No.1＂ were observed. The visual acuity and clinical efficacy were compared between the two groups before and after taking medicine. Results The vision in the treatment group were obviously improved. The total effective rate of the treatment group（78.95%） was significantly higher than that of the control group（55%）, the difference between the two groups was statistically significant（P〈0.05）. Conclusion The self-made ＂Eye Blood No.1＂ could stop bleeding without blood stasis in treatment of traumatic vitreous hemorrhage, improve vision and the quality of life of patients, reduce the rate of blindness, worthy of promotion and application in primary hospitals.

关 键 词：外伤性玻璃体积血 眼血1号 临床观察 

分 类 号：R276.7[医药卫生—中医五官科学] R779.6[医药卫生—中医学]